Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE)

CUSIP: Y95308105

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Ordinary Shares, no par value
Shares outstanding
182,917,028
Total 13F shares
182,758,448
Share change
+19,905,556
Total reported value
$3,108,286,136
Put/Call ratio
86%
Price per share
$17.00
Number of holders
216
Value change
+$421,681,039
Number of buys
140
Number of sells
86

Quarterly Holders Quick Answers

What is CUSIP Y95308105?
CUSIP Y95308105 identifies WVE - Wave Life Sciences Ltd. - Ordinary Shares, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE) as of Q4 2025

As of 31 Dec 2025, Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE) was held by 216 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 182,758,448 shares. The largest 10 holders included GSK plc, RA CAPITAL MANAGEMENT, L.P., FMR LLC, BlackRock, Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., MAVERICK CAPITAL LTD, PRICE T ROWE ASSOCIATES INC /MD/, Darwin Global Management, Ltd., Driehaus Capital Management LLC, and M28 Capital Management LP. This page lists 216 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.